Company Filing History:
Years Active: 2011-2013
Title: Innovations in Cancer Treatment by Tun-Tschu Chang
Introduction
Tun-Tschu Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly in the development of methods for inhibiting tumor cell growth. With a total of two patents to his name, Chang's work focuses on innovative approaches to combat various types of cancer.
Latest Patents
Chang's latest patents include a method for the inhibition of tumor cell growth using (22R)-5α-lanosta-8,24-dien-3β,15α,21-triol. In this patent, he isolated a novel compound from the fruiting body, which exhibits preferential cytotoxicity against human leukemia, pancreatic cancer, esophageal cancer, hepatoma, and cervical cancer cells. Another significant patent relates to a method using dehydrosulphurenic acid to inhibit the growth of leukemia or pancreatic cancer cells. This compound can be utilized as a pharmaceutical composition to effectively inhibit tumor growth.
Career Highlights
Chang is affiliated with Mackay Memorial Hospital, where he conducts his research and development work. His innovative methods and discoveries have the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Some of his notable coworkers include Yu-Jen Chen and Cheng-Jen Chou, who have collaborated with him on various research projects.
Conclusion
Tun-Tschu Chang's contributions to cancer research through his innovative patents highlight the importance of continued research and development in the fight against cancer. His work exemplifies the potential of novel compounds in improving treatment options for patients.